Want to see JP:4109 full AI Analyst Report?
4109 Stock Chart & Stats
¥4150.00
¥10.00(0.22%)
At close: 4:00 PM EST
¥4150.00
¥10.00(0.22%)
Day’s Range― - ―
52-Week Range¥3,890.00 - ¥8,100.00
Previous CloseN/A
Volume63.10K
Average Volume (3M)23.73K
Market Cap
¥69.53B
Enterprise Value¥48.48K
Total Cash (Recent Filing)¥14.82B
Total Debt (Recent Filing)¥5.75B
Price to Earnings (P/E)21.6
Beta0.82
Next Earnings
Aug 06, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield3%
Share Statistics
EPS (TTM)258.39
Shares Outstanding12,973,248
10 Day Avg. Volume21,250
30 Day Avg. Volume23,733
Financial Highlights & Ratios
PEG Ratio2.57
Price to Book (P/B)1.19
Price to Sales (P/S)1.55
P/FCF Ratio39.81
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)256.9
Revenue Forecast (FY)¥39.78B
Bulls Say, Bears Say
Bulls Say
Balance Sheet StrengthThe company’s very low debt-to-equity (~0.11–0.12) and steadily growing equity base provide durable financial resilience. This balance sheet strength lowers refinancing and solvency risk, supports investment or opportunistic M&A, and cushions earnings through industry cycles over the next several months.
Margin RecoveryMeaningful margin improvement indicates sustainable gains in pricing, mix, or cost control rather than one-off items. Higher gross and EBIT margins expand operating leverage, improving cash generation potential and resilience to modest demand swings, supporting earnings stability over a 2–6 month horizon.
Return To Revenue GrowthAfter a downturn, resumed and accelerating revenue growth suggests recovery in end-market demand and improving product traction. Even modest, persistent top-line growth supports capacity utilization and margin maintenance, making near-term cash flow and operating results more predictable.
Bears Say
Volatile Free Cash FlowFree cash flow swings materially year-to-year, implying working-capital sensitivity and uneven capex timing. This volatility reduces predictability of internal funding for dividends, buybacks, or growth investments and raises refinancing or liquidity risk during weaker demand periods.
Cyclical ProfitabilityProfitability has shown marked cyclicality and remains under its 2022 peak, highlighting sensitivity to end-market cycles (e.g., electronics). Such cyclicality complicates forecasting, can pressure margins quickly in downturns, and may limit the sustainability of recent margin gains.
Uneven Shareholder Returns / ROELow and uneven return on equity indicates capital has not consistently delivered strong returns, suggesting limited operating leverage or suboptimal capital allocation. Persistent subpar ROE can constrain long-term shareholder value creation and may signal structural limits to profitability expansion.
Stella Chemifa News
4109 FAQ
What was Stella Chemifa Corporation’s price range in the past 12 months?
Stella Chemifa Corporation lowest stock price was ¥3890.00 and its highest was ¥8100.00 in the past 12 months.
What is Stella Chemifa Corporation’s market cap?
Stella Chemifa Corporation’s market cap is ¥69.53B.
When is Stella Chemifa Corporation’s upcoming earnings report date?
Stella Chemifa Corporation’s upcoming earnings report date is Aug 06, 2026 which is in 14 days.
How were Stella Chemifa Corporation’s earnings last quarter?
Stella Chemifa Corporation released its earnings results on May 14, 2026. The company reported ¥54.35 earnings per share for the quarter, missing the consensus estimate of N/A by N/A.
Is Stella Chemifa Corporation overvalued?
According to Wall Street analysts Stella Chemifa Corporation’s price is currently Overvalued.
Does Stella Chemifa Corporation pay dividends?
Stella Chemifa Corporation pays a Semiannually dividend of ¥90 which represents an annual dividend yield of 3%. See more information on Stella Chemifa Corporation dividends here
What is Stella Chemifa Corporation’s EPS estimate?
Stella Chemifa Corporation’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Stella Chemifa Corporation have?
Stella Chemifa Corporation has 12,973,248 shares outstanding.
What happened to Stella Chemifa Corporation’s price movement after its last earnings report?
Stella Chemifa Corporation reported an EPS of ¥54.35 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 2.805%.
Which hedge fund is a major shareholder of Stella Chemifa Corporation?
Currently, no hedge funds are holding shares in JP:4109
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Stella Chemifa Corporation
Stella Chemifa Corporation, a Japanese company established in 1916 and headquartered in Osaka, specializes as a global manufacturer and supplier of inorganic fluorine compounds. Formerly known as Hashimoto Chemical Corporation until its rebranding in 1997, the company offers a comprehensive product portfolio tailored for diverse industrial applications worldwide. For the electronics sector, Stella Chemifa provides essential materials such as hydrofluoric acid, buffered hydrofluoric acid, and various etching solutions used in the production of semiconductors, liquid crystal displays, and solar cells. It also supplies a range of metal fluorides, including calcium, aluminum, and lithium fluoride, crucial for optical applications, alongside lithium hexafluorophosphate for battery manufacturing. Its offerings extend to numerous boron trifluoride compounds, serving as vital reactive catalysts across different chemical processes. Additionally, the company produces anhydrous hydrofluoric acid and 55% hydrofluoric acid, utilized in surface treatment and as more environmentally conscious alternatives to CFCs. Stella Chemifa also supports the nuclear energy industry with potassium fluoroborate and boric acid, and provides tin fluoride (II) USP for products requiring GMP compliance. Beyond these specialized compounds, the company's extensive catalog includes a broad array of other fluorochemicals, such as fluorosilicic acid, various fluorosilicates, fluoroboric acid, diverse fluoroborates, and a selection of ammonium, sodium, and potassium fluorides. Complementing its manufacturing operations, Stella Chemifa offers logistics services for the transportation of specialized chemical substances, high-pressure gases, and hazardous materials. Demonstrating a commitment to innovation, the company is also actively involved in the development of Boron Neutron Capture therapy for cancer treatment.
Technical Analysis
Osaka Organic Chemical Industry Ltd.
―
Sumitomo Seika Chemicals Co., Ltd.
―
Sakai Chemical Industry Co., Ltd.
―
Dainichiseika Color & Chemicals Mfg.Co., Ltd.
―
Nippon Fine Chemical Co., Ltd.
―





